PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
31.29%
Net income growth 1.25-1.5x CNQ's 21.91%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
6.89%
D&A growth well above CNQ's 0.97%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-0.42%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-400.77%
Both reduce yoy usage, with CNQ at -54.17%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce yoy usage, with CNQ at -54.17%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-5042.90%
Negative yoy while CNQ is 81.53%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-29.47%
Both yoy CFO lines are negative, with CNQ at -8.27%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-25.08%
Both yoy lines negative, with CNQ at -6.84%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.03%
We reduce yoy other investing while CNQ is 643.11%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-72.10%
Both yoy lines negative, with CNQ at -3.97%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.15%
We cut debt repayment yoy while CNQ is 91.40%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
132.61%
Stock issuance far above CNQ's 60.72%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
68.97%
Similar buyback growth to CNQ's 63.20%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.